INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Public company

PVCTPROVECTUS BIOPHARMACEUTICALS, INC.

CIK 0000315545

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score9
Connections2with evidence

PVCT · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
PE
Pershing EdwardDirector, CEO, 10% Owner
PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
Option exercise
M—Oct 23, 2026Oct 23, 2026
traded Oct 23, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Pershing EdwardDirector, CEO · Nov 28, 2025
9
PE
Pershing EdwardDirector, CEO, 10% Owner
PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
Option exercise
M
—
7,599 sh
Oct 23, 2026
Oct 23, 2026
traded Oct 23, 2026
+0d
SEC FORM 4

Evidence

8
PE
Pershing EdwardDirector, CEO
PVCTPROVECTUS BIOPHARMACEUTICALS, INC.
Grant or award
A—Nov 26, 2025Nov 28, 2025
traded Nov 26, 2025
+2dSEC FORM 4

Evidence